-
Hu-manity.co launches blockchain app to help users sell their healthcare data
fiercebiotech
September 07, 2018
Built with IBM’s blockchain technology, the ledger will log people’s authorization for commercial use of their personal information and allow them to choose to share it for specific research purposes. (Pixabay / Geralt)
-
FDA takes new steps to advance digital health, opening docket to solicit feedback on software products
worldpharmanews
June 05, 2018
Today, the FDA is opening a docket to solicit feedback on important provisions of the 21st Century Cures Act ("Cures Act").
-
GSK, Propeller expand digital health collaboration
fiercebiotech
August 25, 2017
The Propeller sensor and GlaxoSmithKline's Ellipta inhaler (left) and the Propeller app.
-
Livongo recruits former 23andMe President Andy Page
fiercebiotech
August 23, 2017
Livongo's connected blood glucose meter sends glucose data to the cloud, and its digital diabetes management service provides patients with advice based on this data.
-
9 companies will play a huge role in shaping the FDA’s new approach to digital health
fiercehealthcare
August 09, 2017
As the FDA initiate a big reexamine of its plan to regulating health technology, some software companies are ready to have a huge impact on the agency’s methodology moving forward.
-
Biomedical Institute for Global Health Research and Technology (BIGHEART) at NUS and Holmusk Partner
en-cphi.cn
March 27, 2017
CO2RE Intima Now First In-Office Laser Procedure CE Marked for the Treatment of Vaginal Atrophy and Rejuvenation
-
Singapore strengthens digital health innovation
biospectrumasia
March 08, 2017
Singapore-based EDBI and Royal Philips are progressing on their joint investment partnership to drive the creation and commercialization of leading connected health solutions
-
Novo strikes up personalised diabetes treatment deal with Glooko
pharmafile
January 17, 2017
Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with a range of issues affecting patients with type 1 and 2 diabetes including treatment adherence and blood glucose management.